*This is my idea and not something that will happen. I am not a professional analytic or trader, do not take this as a financial advice.
Remember do your own research on the company before buying or sell and do it at your own risk. Also like any other investment there is a risk of loss or earn money. *
OGEN in a short-term Idea in the 4 hour Chart looks very...
***Please don't take this as a financial advice, remember I'm not a professional analytic, this whole idea is based on my knowledge and opinion. ***
This is only my Idea, don't buy or sell because of my idea. Do your own research in the company before deciding either buy or sell at your own risk.
The stock in the 1 D chart is about to cross the SMA 200 and that...
AMEX:OGEN is going to rip into earnings then pull back right before then pop for 100% or more post earnings. Here are my price targets placed for the next week every few days starting with next Monday.
DD:
OGEN has
*1 drug for Oral Mucosis just finished Phase 2 trial, FULL data will be release on earnings call and ironically at the same time they have $15...
got a big drop PT downgrade and shares fall 46% after results miss but they do have Er on the way. Small catalyst
Enter over $.42 Sell close to the gap, This could start a gap fill before ER giving you room to profit. Be careful. Stay respective to your stoploss.
The chart is explained in the same chart. Im Bullish on it and it have a small uptrend at the end of the day today. Expecting something more higher next week after the meeting in Eurpoe.
*Do you own DD and don't buy because of me***
This is my Daily Portfolio Trade Study. OGEN still have that gap at .69 and an old support at .45 cents. Today the SMA line worked as a support at .52 and now for tomorrow can work as a support at .53. We faced today a strong resistance at .59 , the RSI is at 47 and the MACD looked bearish at the close today.
*Personal Opinion* The company received great and...
Actually it have a resistance at .60 and a support at .54 on sept 24th 2019. RSI at 51 and MACD just start to cross. During a few days we can see a .45 support and a Gap to .69 cents. The SMA right now work as a support also if they break the temporary support at .54. In my personal opinion if the stock do an up trend we can test .69 again or above with a limit...
Do your own DD on this stock and the catalyst but chart, data, news, pipeline, timeline..... all together say BUY @ 0.52 now on STUPID low volume, Cash out @ 0.75-0.80 Next week. Rebuy on dip to 0.69 and hold til Phase 2 data released early Nov with earnings report and cash out @ 3.09 then rebuy in Dec for 1.50 and hold til summer for 3.50 and sell again... LONG...
extreme powerful the double support ai 40 cents are
the gain ratio is 1.5 1.10
rsi bulding mometum
oversold trend
ma taking over in bullish ways
strong double support area
patterns sow this type of bounces
targets
0.62 0.60 trigger for reversal also firts target
1.14
1.61
2.0 or 1.96
3$ 3.60 areA
******HOT STOCK ON THE WATCHLIST FOR A SWING TRADE IN THE WEEKS TO COME, SPECULATION AND RUMORS HAVE BROUGHT IT THE ATTENTION OF MANY AND SOME ACCUMULATION HAS STARTED TO TAKE PLACE. JUST LIKE MOST BIO STOCKS, AMEX:OGEN TENDS TO MOVE VERY FAST FOR GREAT GAINS ON TRIAL AND DATA RELEASE, SO SET YOUR ALERTS FOR SPIKES.
AVERAGE ANALYSTS PRICE TARGET ...
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oragenics Inc (OGEN) today and set a price target of $2. The company’s shares closed yesterday at $0.55, close to its 52-week low of $0.38.
Selvaraju observed:
“We believe the Phase 2 study could report top-line results in early 2020. If AG013 could significantly reduce the duration and lower the...
Looking very bullish@ 15,30,45 and 1h time frame.
Order is set @ .99
target 5-20 %
stop loss .95
Oragenics Fast Track Drug AG013 Going into Phase II Clinicals
